Lyme Disease Support 1 NDC 66096-722

NDC codes

FDA NDC Directory

Product NDC (as listed)66096-722Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66096-0722Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66096-722-05	66096072205	59 mL in 1 BOTTLE, DROPPER (66096-722-05)Marketed from Nov 20, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lyme Disease Support 1
Generic name (nonproprietary): alumen, calcarea carbonica, dna, ferrum phosphoricum, hepar sulphuris calcareum, kali carbonicum, kali muriaticum, kali sulphuricum, magnesia phosphorica, natrum muriaticum, natrum phosphoricum, rna, silicea.
Active ingredients: Potassium alum — 12 [hp_X]/59mLOyster shell calcium carbonate, Crude — 6 [hp_X]/59mLHerring sperm DNA — 4 [hp_C]/59mLFerrosoferric phosphate — 6 [hp_X]/59mLCalcium sulfide — 6 [hp_X]/59mLPotassium carbonate — 6 [hp_X]/59mLPotassium chloride — 6 [hp_X]/59mLPotassium sulfate — 6 [hp_X]/59mLMagnesium phosphate, Dibasic trihydrate — 6 [hp_X]/59mLSodium chloride — 6 [hp_X]/59mLSodium phosphate, Dibasic, Heptahydrate — 6 [hp_X]/59mLSaccharomyces cerevisiae RNA — 4 [hp_C]/59mLSilicon dioxide — 12 [hp_X]/59mL
Dosage form: Liquid
Route: Oral
Labeler: OHM PHARMA INC.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Nov 20, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 66096-722_d44b40e1-a611-4469-e053-2a95a90aa702SPL ID d44b40e1-a611-4469-e053-2a95a90aa702SPL set ID 035e75d6-aeef-4dfd-b076-9d3d8e4a5086UNII 1L24V9R23S, 2E32821G6I, 51FI676N6F, 91GQH8I5F7, 1MBW07J51Q, BQN1B9B9HA, 660YQ98I10, 1K573LC5TV, HF539G9L3Q, 451W47IQ8X, 70WT22SF4B, J17GBZ5VGX, ETJ7Z6XBU4UPC 0366096722050
Pharmacologic class: Calculi Dissolution Agent; Osmotic Laxative; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466096072205 followed by a unit qualifier and the quantity

Package 66096-0722-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 29, 2021.

Indications (excerpt from the label)

USES: Supports the immune systems response to Lyme disease symptoms.* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)